Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Buy
2,253
+124
+6% +$15.4K 0.06% 434
2026
Q1
$226K Sell
2,129
-959
-31% -$109K 0.05% 552
2025
Q4
$328K Buy
+3,088
New +$312K 0.08% 293

Other funds holding ACA

Abel Hall LLC's ACA Position: Q2 2026 in Review

Abel Hall LLC increased its Arcosa (ACA) stake by 5.8% in Q2 2026, buying an estimated $15.4K and bringing the position to 2,253 shares worth $327K. The position accounts for 0.06% of the portfolio, ranked #434.

Abel Hall LLC first reported a position in ACA in Q4 2025 and has held it in 3 quarters since. The position peaked at $328K in Q4 2025. 102 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Abel Hall LLC held 2,253 shares of Arcosa worth $327K as of Q2 2026.
  • Abel Hall LLC bought 124 Arcosa shares in Q2 2026, an estimated $15.4K.
  • Arcosa made up 0.06% of Abel Hall LLC's portfolio in Q2 2026, its #434 holding.
  • Abel Hall LLC first reported a position in Arcosa in Q4 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's Arcosa position peaked at $328K in Q4 2025.
  • 102 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.